Literature DB >> 12060741

HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae.

Sayuri Sakuragi1, Toshiyuki Goto, Kouichi Sano, Yuko Morikawa.   

Abstract

Expression of retroviral Gag protein in yeast has previously shown Gag targeting to the plasma membrane but little or no production of Gag virus-like particles (VLPs). Here we show that, after removal of the cell wall, the expression of HIV type 1 Gag protein in Saccharomyces cerevisiae spheroplasts allowed simultaneous budding of VLPs from the plasma membrane. Our data show that (i) the VLPs released from yeast spheroplasts were spherical and had morphological features, such as membrane apposed electron-dense layers, characteristic of the immature form of HIV particles; (ii) the VLPs were completely enclosed in the plasma membrane derived from yeast, which is denser than that of higher eukaryotic cells; (iii) the VLP Gag shells remained intact after treatment of nonionic detergent; and (iv) the VLPs were released soon after removal of the cell wall and accumulated up to 300 microg/liter of culture. Our results also show that VLP production was abolished by amino acid substitution of the Gag N-terminal myristoylglycine and impaired when Gag C-terminal deletions were extended beyond the nucleocapsid domain. These results were consistent with those obtained previously in higher eukaryotic expression systems, suggesting that similar Gag domains were used for VLP assembly. We suggest that the system described here offers significant advantages for studying host factors required for VLP budding. The system also may be available for production of vector virus-free VLPs for practical applications such as vaccine development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060741      PMCID: PMC123002          DOI: 10.1073/pnas.082281199

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.

Authors:  H G Göttlinger; T Dorfman; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Properties of avian retrovirus particles defective in viral protease.

Authors:  L Stewart; G Schatz; V M Vogt
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

3.  Form, function, and use of retroviral gag proteins.

Authors:  J W Wills; R C Craven
Journal:  AIDS       Date:  1991-06       Impact factor: 4.177

4.  Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.

Authors:  V Karacostas; K Nagashima; M A Gonda; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Rous sarcoma virus expression in Saccharomyces cerevisiae: processing and membrane targeting of the gag gene product.

Authors:  D Bonnet; P F Spahr
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  IRA2, a second gene of Saccharomyces cerevisiae that encodes a protein with a domain homologous to mammalian ras GTPase-activating protein.

Authors:  K Tanaka; M Nakafuku; F Tamanoi; Y Kaziro; K Matsumoto; A Toh-e
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

7.  MSI1, a negative regulator of the RAS-cAMP pathway in Saccharomyces cerevisiae.

Authors:  R Ruggieri; K Tanaka; M Nakafuku; Y Kaziro; A Toh-e; K Matsumoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

8.  Subcellular localization of recombinant truncated Gag precursor proteins of HIV expressed in Saccharomyces cerevisiae.

Authors:  R Biemans; D Thines; D Gheysen; T Rutgers; T Cabezon
Journal:  AIDS       Date:  1992-06       Impact factor: 4.177

9.  The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.

Authors:  J Park; C D Morrow
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Myristoylation-dependent membrane targeting and release of the HTLV-I Gag precursor, Pr53gag, in yeast.

Authors:  T Hayakawa; T Miyazaki; Y Misumi; M Kobayashi; Y Fujisawa
Journal:  Gene       Date:  1992-10-01       Impact factor: 3.688

View more
  22 in total

Review 1.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

2.  HIV-1 virus-like particles produced by stably transfected Drosophila S2 cells: a desirable vaccine component.

Authors:  Lifei Yang; Yufeng Song; Xiaomin Li; Xiaoxing Huang; Jingjing Liu; Heng Ding; Ping Zhu; Paul Zhou
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

3.  Novel postentry inhibitor of human immunodeficiency virus type 1 replication screened by yeast membrane-associated two-hybrid system.

Authors:  Emiko Urano; Noriko Kuramochi; Reiko Ichikawa; Somay Yamagata Murayama; Kosuke Miyauchi; Hiroshi Tomoda; Yutaka Takebe; Milan Nermut; Jun Komano; Yuko Morikawa
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

4.  The cellular factors Vps18 and Mon2 are required for efficient production of infectious HIV-1 particles.

Authors:  Yuriko Tomita; Takeshi Noda; Ken Fujii; Tokiko Watanabe; Yuko Morikawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

5.  Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs.

Authors:  Yasuko Tsunetsugu-Yokota; Yuko Morikawa; Maya Isogai; Ai Kawana-Tachikawa; Takashi Odawara; Tetsuya Nakamura; Fernanda Grassi; Brigitte Autran; Aikichi Iwamoto
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.

Authors:  Baojing Lu; Yi Huang; Li Huang; Bao Li; Zhenhua Zheng; Ze Chen; Jianjun Chen; Qinxue Hu; Hanzhong Wang
Journal:  Immunology       Date:  2010-04-06       Impact factor: 7.397

7.  Defect of human immunodeficiency virus type 2 Gag assembly in Saccharomyces cerevisiae.

Authors:  Yuko Morikawa; Toshiyuki Goto; Daisuke Yasuoka; Fumitaka Momose; Tetsuro Matano
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

8.  HIV-1 Gag release from yeast reveals ESCRT interaction with the Gag N-terminal protein region.

Authors:  Birgit Meusser; Bettina Purfuerst; Friedrich C Luft
Journal:  J Biol Chem       Date:  2020-09-28       Impact factor: 5.157

9.  Trans-packaging of human immunodeficiency virus type 1 genome into Gag virus-like particles in Saccharomyces cerevisiae.

Authors:  Naoki Tomo; Toshiyuki Goto; Yuko Morikawa
Journal:  Microb Cell Fact       Date:  2013-03-26       Impact factor: 5.328

10.  ESCRT-independent budding of HIV-1 gag virus-like particles from Saccharomyces cerevisiae spheroplasts.

Authors:  Andrew P Norgan; Jacqueline R E Lee; Andrea J Oestreich; Johanna A Payne; Eugene W Krueger; David J Katzmann
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.